IQGAP3 promotes EGFR-ERK signaling and the growth and metastasis of lung cancer cells.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 4029748)

Published in PLoS One on May 21, 2014

Authors

Ying Yang1, Wei Zhao1, Qing-Wen Xu1, Xiao-Song Wang1, Yu Zhang1, Jun Zhang1

Author Affiliations

1: Department of Immunology, School of Basic Medical Sciences, Key Laboratory of Medical Immunology of Ministry of Public Health, Peking University Health Science Center, Beijing, P. R. China.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (1987) 49.88

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55

Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71

EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol (2006) 10.39

Multidisciplinary management of lung cancer. N Engl J Med (2004) 7.13

Epidermal growth factor receptor (EGFR) signaling in cancer. Gene (2005) 6.04

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer (2001) 5.96

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell (2003) 5.06

Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93

IQGAP1: a key regulator of adhesion and migration. J Cell Sci (2005) 2.65

IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol (2006) 2.63

IQGAP proteins are integral components of cytoskeletal regulation. EMBO Rep (2003) 2.17

IQGAP1 binds ERK2 and modulates its activity. J Biol Chem (2004) 1.99

p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene (2011) 1.86

The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer (2002) 1.82

The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. Eur J Cancer (2000) 1.82

IQGAP1 and its binding proteins control diverse biological functions. Cell Signal (2011) 1.77

The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol Cell Biol (1996) 1.77

Identification of a human rasGAP-related protein containing calmodulin-binding motifs. J Biol Chem (1994) 1.73

IQGAP1 promotes cell motility and invasion. J Biol Chem (2003) 1.72

Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene (2010) 1.60

IQGAP1 regulation and roles in cancer. Cell Signal (2009) 1.58

IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton. FEBS Lett (2003) 1.38

Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res (2004) 1.36

Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One (2011) 1.30

EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. FEBS J (2009) 1.30

Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. Mol Cell Biol (2008) 1.27

IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci (2007) 1.24

IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nat Cell Biol (2008) 1.14

EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. Int J Med Sci (2013) 1.14

Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc Natl Acad Sci U S A (2011) 1.11

The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer. Clin Cancer Res (2010) 1.09

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC Cancer (2010) 1.00

Novel targets for lung cancer therapy: part I. J Clin Oncol (2002) 0.97

IQGAP1 in microbial pathogenesis: Targeting the actin cytoskeleton. FEBS Lett (2011) 0.97

DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization. Cancer Genet Cytogenet (2006) 0.96

Novel targets for lung cancer therapy: part II. J Clin Oncol (2002) 0.94

Roles of IQGAP1 in cell polarization and migration. Novartis Found Symp (2005) 0.93

State of the art:lung cancer in China. Ann Thorac Cardiovasc Surg (2003) 0.92

Clustering of molecular alterations in gastroesophageal carcinomas. Neoplasia (2004) 0.91

EGF receptor as a therapeutic target. Lung Cancer (2003) 0.90

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma. Eur J Cancer (2011) 0.89

An integrated genome-wide approach to discover tumor-specific antigens as potential immunologic and clinical targets in cancer. Cancer Res (2012) 0.86

Non-small cell lung cancer--genetic predictors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2013) 0.86

Involvement of IQGAP3, a regulator of Ras/ERK-related cascade, in hepatocyte proliferation in mouse liver regeneration and development. J Cell Physiol (2009) 0.85

Signal transduction pathways as novel therapy targets in lung cancer. Lung Cancer (2004) 0.81